BRIEF

on BV Holding AG (isin : CH0013396012)

SKAN Reports Preliminary Figures for 2024

SKAN Group AG, a leader in isolator systems for aseptic production in the pharmaceutical industry, has released its preliminary financial figures for 2024. The company anticipates net sales of approximately CHF 360 million, marking an increase from the CHF 320 million recorded in 2023. EBITDA is expected to reach around CHF 56 million, compared to CHF 50.1 million last year. Additionally, order intake is projected at CHF 360 million, a rise from CHF 295.1 million in 2023.

The detailed financial results for 2024 will be published on March 25, 2025. Alongside these, SKAN will release its Annual Report and year-end presentation, with an investor and media conference planned in Zurich.

R. E.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all BV Holding AG news